Servier Monde is a Boston-based, commercial-stage biopharmaceutical company that was established in the U.S. in 2018 by the Servier Group. As a privately held organization, Servier is dedicated to advancing innovative science and addressing unmet therapeutic needs, with a strong focus on patient-centered decision-making. The company emphasizes diversity, equity, and inclusion within the industry, fostering an environment that values equitable treatment for all. Servier is committed to hiring passionate and innovative individuals, and it offers a comprehensive benefits package to its employees.